These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32859328)

  • 21. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.
    Hu YM; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ; Guo AS; Li JA; Su JB
    Endocrine; 2018 May; 60(2):292-300. PubMed ID: 29411305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
    Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
    Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of metformin on glycaemic variability in combination with insulin in overweight/obese patients with type 1 diabetes.
    Poh Shean W; Chin Voon T; Long Bidin MBB; Adam NLB
    J R Coll Physicians Edinb; 2023 Jun; 53(2):94-103. PubMed ID: 37154572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-restricted eating improves measures of daily glycaemic control in people with type 2 diabetes.
    Parr EB; Steventon-Lorenzen N; Johnston R; Maniar N; Devlin BL; Lim KHC; Hawley JA
    Diabetes Res Clin Pract; 2023 Mar; 197():110569. PubMed ID: 36738837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial.
    Heianza Y; Zhou T; Wang X; Furtado JD; Appel LJ; Sacks FM; Qi L
    Diabetologia; 2024 Mar; 67(3):506-515. PubMed ID: 38052941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
    Christensen MB; Gæde P; Hommel E; Gotfredsen A; Nørgaard K
    Diabetes Metab; 2020 Feb; 46(1):61-65. PubMed ID: 30796973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a carbohydrate-reduced high-protein diet delivered with meal kits to Danish people with type 2 diabetes: protocol for a 12-month randomised controlled trial.
    Kopp LHP; Søgaard-Hansen CM; Zachhau KM; Bastkjær RM; Andersen BV; Budtz-Jørgensen E; Byrne DV; Chaaban N; Holst JJ; Klindt TB; Magkos F; Ozenne B; Samkani A; Skytte MJ; Madsbad S; Krarup T; Thomsen MN
    BMJ Open; 2024 Aug; 14(8):e084686. PubMed ID: 39142677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
    Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
    Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin.
    Htet TD; Godneva A; Liu Z; Chalmers E; Kolobkov D; Snaith JR; Richens R; Toth K; Danta M; Hng TM; Elinav E; Segal E; Greenfield JR; Samocha-Bonet D
    BMJ Open; 2020 Oct; 10(10):e037859. PubMed ID: 33040003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The beneficial short-term effects of a high-protein/low-carbohydrate diet on glycaemic control assessed by continuous glucose monitoring in patients with type 1 diabetes.
    Dimosthenopoulos C; Liatis S; Kourpas E; Athanasopoulou E; Driva S; Makrilakis K; Kokkinos A
    Diabetes Obes Metab; 2021 Aug; 23(8):1765-1774. PubMed ID: 33769666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial.
    Ranjan A; Schmidt S; Damm-Frydenberg C; Holst JJ; Madsbad S; Nørgaard K
    Diabetes Obes Metab; 2017 Oct; 19(10):1479-1484. PubMed ID: 28345762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of High Versus Low Carbohydrate Intake in the Morning on Glycemic Variability and Glycemic Control Measured by Continuous Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus-A Randomized Crossover Study.
    Rasmussen L; Christensen ML; Poulsen CW; Rud C; Christensen AS; Andersen JR; Kampmann U; Ovesen PG
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycaemic stability of a cyclist with Type 1 diabetes: 4011 km in 20 days on a ketogenic diet.
    Nolan J; Rush A; Kaye J
    Diabet Med; 2019 Nov; 36(11):1503-1507. PubMed ID: 31197870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial.
    Sterner Isaksson S; Ólafsdóttir AF; Ivarsson S; Imberg H; Toft E; Hallström S; Rosenqvist U; Ekström M; Lind M
    Lancet Reg Health Eur; 2024 Feb; 37():100799. PubMed ID: 38362553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term exercise training reduces glycaemic variability and lowers circulating endothelial microparticles in overweight and obese women at elevated risk of type 2 diabetes.
    Rafiei H; Robinson E; Barry J; Jung ME; Little JP
    Eur J Sport Sci; 2019 Sep; 19(8):1140-1149. PubMed ID: 30776253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The continuous spectrum of glycaemic variability changes with pancreatic islet function: A multicentre cross-sectional study in China.
    Zhang L; Guo K; Tian Q; Ye J; Ding Z; Zhou Q; Wu J; Fan L; Pan N; Niu X; Zhao Q; Ma Y; Jiang H; Huang G; Li X; Zhou Z; Yang L
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3579. PubMed ID: 36214297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of high circulating testosterone with increased glycaemic variability in type 2 diabetes: A cross-sectional study in China.
    Ding B; Sun R; Zhai XF; Lu TT; Cheng L; Li FF; Hu Y; Ma JH
    Diabetes Metab Res Rev; 2019 May; 35(4):e3126. PubMed ID: 30614187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
    Aberer F; Lichtenegger KM; Smajic E; Donsa K; Malle O; Samonigg J; Höll B; Beck P; Pieber TR; Plank J; Mader JK
    Diabetes Obes Metab; 2019 Mar; 21(3):584-591. PubMed ID: 30328252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
    Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
    Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.